In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639 clinical isolates and a number of in vitro-selected resistant mutants. BMY-28142 was the most potent compound against the members of the family Enterobacteriaceae with a MIC for...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1985
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180098/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859244/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.574 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|